Shire Pharmaceuticals has revised the summary of product characteristics for Meptid (meptazinol) injection 100mg/ ml and tablets. The following statement has been added to the undesirable effects section: “Occasional reports of psychiatric disorders (hallucination, confusion, depression) have been received, but any causal relationship with the use of meptazinol has not been established.”